Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cella

Showing results (701-710 of 1,017) with videos related to

Pageof 102
Sort By:
Cancer|April 3, 2008
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaireJanice N Cormier, Merrick I Ross, Jeffrey E Gershenwald, et al.
Cancer|April 1, 2021
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trialGelareh Sadigh, Robert J Gray, Joseph A Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2007
Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiativeSofia F Garcia, David Cella, Steven B Clauser, et al.
Journal of Clinical Epidemiology|April 11, 2021
The PROMIS<sup>Ⓡ</sup>-Plus-Osteoarthritis of the Knee (OAK) profile measure integrates generic and condition-specific content to enhance relevance and efficiencySusan E Yount, Michael A Kallen, Karen E Schifferdecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group StudyGini F Fleming, Virginia L Brunetto, David Cella, et al.
World Journal of Oncology|November 18, 2017
Quality of Life in Patients with Advanced Cancer Using the Functional Assessment of Cancer Therapy-General Assessment Tool: A Literature ReviewMarko Popovic, Nicholas Lao, Gillian Bedard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 12, 2012
Biological pathways and genetic mechanisms involved in social functioningJuan R Ordoñana, Meike Bartels, Dorret I Boomsma, et al.
Current Opinion in Supportive and Palliative Care|March 12, 2025
Evaluation of the EORTC QLQ-C15-PAL and the FACIT-PAL-14 in assessing the quality of life in patients with advanced cancerPaula Tur, Eva Oldenburger, Andrew Bottomley, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast CancerRicardo Fernandes, Terry L Ng, Mashari Jemaan Alzahrani, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 3, 2019
Interviewer- versus self-administration of PROMIS® measures for adults with traumatic injuryPamela A Kisala, Aaron J Boulton, Matthew L Cohen, et al.
Pageof 102

Showing results (701-710 of 1,017) with videos related to

Sort By:
Pageof 102
Cancer|April 3, 2008
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaireJanice N Cormier, Merrick I Ross, Jeffrey E Gershenwald, et al.
Cancer|April 1, 2021
Breast cancer patients' insurance status and residence zip code correlate with early discontinuation of endocrine therapy: An analysis of the ECOG-ACRIN TAILORx trialGelareh Sadigh, Robert J Gray, Joseph A Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2007
Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiativeSofia F Garcia, David Cella, Steven B Clauser, et al.
Journal of Clinical Epidemiology|April 11, 2021
The PROMIS<sup>Ⓡ</sup>-Plus-Osteoarthritis of the Knee (OAK) profile measure integrates generic and condition-specific content to enhance relevance and efficiencySusan E Yount, Michael A Kallen, Karen E Schifferdecker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group StudyGini F Fleming, Virginia L Brunetto, David Cella, et al.
World Journal of Oncology|November 18, 2017
Quality of Life in Patients with Advanced Cancer Using the Functional Assessment of Cancer Therapy-General Assessment Tool: A Literature ReviewMarko Popovic, Nicholas Lao, Gillian Bedard, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 12, 2012
Biological pathways and genetic mechanisms involved in social functioningJuan R Ordoñana, Meike Bartels, Dorret I Boomsma, et al.
Current Opinion in Supportive and Palliative Care|March 12, 2025
Evaluation of the EORTC QLQ-C15-PAL and the FACIT-PAL-14 in assessing the quality of life in patients with advanced cancerPaula Tur, Eva Oldenburger, Andrew Bottomley, et al.
Current Oncology (Toronto, Ont.)|August 25, 2023
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast CancerRicardo Fernandes, Terry L Ng, Mashari Jemaan Alzahrani, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 3, 2019
Interviewer- versus self-administration of PROMIS® measures for adults with traumatic injuryPamela A Kisala, Aaron J Boulton, Matthew L Cohen, et al.
Pageof 102